Biocept Inc. has received a $10 million loan from Oxford Finance LLC that pays off the outstanding items on Biocept’s balance sheet.
Biocept (Nasdaq: BIOC) began trading publicly in February with a $19 million initial public offering, and the loan will help free up proceeds from the company’s IPO to fund the commercialization of its cancer detection tests.
For more information: Click here.
